Literature DB >> 6736114

Aortic valve replacement in elderly patients.

Y Glock, R Pecoul, A Cerene, J Laguerre, P Puel.   

Abstract

The results for 62 consecutive patients aged 70 or more given aortic valve replacement (A.V.R.) between 1970 and 1982 are reported. All the patients were in the New York Heart Association (N.Y.H.A.) functional class III (29%) or IV (71%); 54.8% had angina and 30.6% had experienced syncope. Forty patients had aortic stenosis (A.S.), 10 had aortic regurgitation and 12 had mixed aortic valve disease. The operative myocardial infarction rate was 6.4%. Tilting disk valves were used. Eighty percent of the patients were anticoagulated with Warfarin whilst twenty percent received only antiplatelet drugs. All the patients were followed up for a mean period of 26 months; late mortality was 22.6% with 4.8% cardiac deaths. The thromboembolic rate was 1.6% and the disinsertion rate was 3.2%. Cerebral stroke was fatal in 3 cases in anticoagulated patients but the mechanism of the accident was not known. At the termination of the study 93% of surviving patients were in N.Y.H.A. class I or II. No patient was in class IV. The probability of five year survival is 71% for the entire group.

Entities:  

Mesh:

Year:  1984        PMID: 6736114

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Aortic valve replacement in septuagenarians.

Authors:  O Kaplan; V Yakirevich; B A Vidne
Journal:  Tex Heart Inst J       Date:  1985-12

2.  Percutaneous aortic balloon dilatation for calcific aortic stenosis in elderly patients: immediate haemodynamic results and short-term follow up.

Authors:  C Di Mario; K J Beatt; P de Feyter; M van den Brand; C E Essed; P W Serruys
Journal:  Br Heart J       Date:  1987-12

3.  Aortic valve replacement in elderly patients with aortic stenosis.

Authors:  E Straumann; W Kiowski; I Langer; E Grädel; P Stulz; D Burckhardt; M Pfisterer; F Burkart
Journal:  Br Heart J       Date:  1994-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.